Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001387131-20-006309
Filing Date
2020-07-10
Accepted
2020-07-10 16:40:12
Documents
1
Group Members
DAVID BONDERMANJAMES G. COULTER

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D allo-sc13da_062520.htm SC 13D/A 67465
  Complete submission text file 0001387131-20-006309.txt   69061
Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Filed by) CIK: 0001495741 (see all company filings)

EIN.: 271650453 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90685 | Film No.: 201023537
SIC: 2836 Biological Products, (No Diagnostic Substances)